BIOHLDG Cubaan Untuk Keluar Dari Segitiga Pengumpulan
BIOHLDG berlegar-legar didalam segitiga pengumpulan sejak sebulan yang lalu. Semalam director Biohldg ada membuat pembelian saham Biohldg sebanyak 5,380,000 unit dan pada petang tadi ada satu news baru seperti berikut:
"The Board of Directors of Bioalpha Holdings Berhad (“Bioalpha” or “the Company”) wishes to announce that Bioalpha (HK) Limited, the wholly-owned subsidiary of Bioalpha had on 26 August 2020 incorporated a new wholly-owned subsidiary in Hainan, China with the name “Bioalpha (Hainan) Health Biotechnology Limited” under the Foreign Enterprise Law of the People’s Republic of China, Company Law of the People’s Public of China and relevant Chinese laws and regulations with the authorised share capital of Renminbi (“RMB”) 15,000,000 and the intended paid up capital of RMB 15,000,000 only (“the Incorporation”).
The principal activities of Bioalpha (Hainan) Health Biotechnology Limited are health food production, import and export; food products trading and selling; pharmaceutical goods production, import and export; production, sales, processing, transportation, storage and other related services of agricultural products."
Sesuatu yang menarik untuk future earning BIOHLDG. Berkemungkinan persediaan untuk menjadi pengedar vaksin covid19 di China. Sama-sama kita perhati rapat dan sediakan trading plan. Aras tertinggi sepanjang zaman untuk BIOHLDG adalah di aras 0.395. Aras sokongan (support) adalah di 0.300 dan 0.270. Selagi tidak bocor ada peluang untuk membuat pantulan ke atas. (Sekadar kajian dan pembelajaran.
"The Board of Directors of Bioalpha Holdings Berhad (“Bioalpha” or “the Company”) wishes to announce that Bioalpha (HK) Limited, the wholly-owned subsidiary of Bioalpha had on 26 August 2020 incorporated a new wholly-owned subsidiary in Hainan, China with the name “Bioalpha (Hainan) Health Biotechnology Limited” under the Foreign Enterprise Law of the People’s Republic of China, Company Law of the People’s Public of China and relevant Chinese laws and regulations with the authorised share capital of Renminbi (“RMB”) 15,000,000 and the intended paid up capital of RMB 15,000,000 only (“the Incorporation”).
The principal activities of Bioalpha (Hainan) Health Biotechnology Limited are health food production, import and export; food products trading and selling; pharmaceutical goods production, import and export; production, sales, processing, transportation, storage and other related services of agricultural products."
Sesuatu yang menarik untuk future earning BIOHLDG. Berkemungkinan persediaan untuk menjadi pengedar vaksin covid19 di China. Sama-sama kita perhati rapat dan sediakan trading plan. Aras tertinggi sepanjang zaman untuk BIOHLDG adalah di aras 0.395. Aras sokongan (support) adalah di 0.300 dan 0.270. Selagi tidak bocor ada peluang untuk membuat pantulan ke atas. (Sekadar kajian dan pembelajaran.